Cargando…

CD8 T-Cell Responses in Incident and Prevalent Human Papillomavirus Types 16 and 18 Infections

CD8 T-cell responses were examined in subjects with incident (new following negative visits) or prevalent (lasting ≥ 4 months) human papillomavirus type 16 (HPV16) or human papillomavirus (HPV18) infection. The groups were chosen from a cohort of women being followed every 4 months with cervical cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coleman, Hannah N., Moscicki, Anna-Barbara, Farhat, Sepideh N., Gupta, Sushil K., Wang, Xuelian, Nakagawa, Mayumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316950/ https://www.ncbi.nlm.nih.gov/pubmed/22523697 http://dx.doi.org/10.5402/2012/854237

Ejemplares similares

Prevalence and Transmission of Beta and Gamma Human Papillomavirus in Heterosexual Couples
por: Moscicki, Anna-Barbara, et al.
Publicado: (2017)

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2016)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Prevalence of Human Papillomavirus subtypes 16 and 18 among Yemeni Patients with Cervical Cancer
por: Ahmed, Hussain Gadelkarim, et al.
Publicado: (2017)

Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion
por: Ravilla, Rahul, et al.
Publicado: (2019)

Sexual behavior and infection with cervical human papillomavirus types 16 and 18
por: Itarat, Yuwadee, et al.
Publicado: (2019)

GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8(+) T cell responses leading to tumor regression
por: Esquerré, Michaël, et al.
Publicado: (2017)

Human papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16.
por: Arends, M. J., et al.
Publicado: (1995)

Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule
por: Germar, Maria Julieta, et al.
Publicado: (2017)

Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan
por: Tanaka, Kohsei, et al.
Publicado: (2022)

Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
por: Ji, Jia, et al.
Publicado: (2012)

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
por: Huh, Warner K., et al.
Publicado: (2014)

Persistence of human papillomavirus 16, 18 and 52 variants in Inuit women from Northern Quebec, Canada
por: Gauthier, Barbara, et al.
Publicado: (2019)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

A high prevalence of human papillomavirus 16 and 18 co-infections in cervical biopsies from southern Brazil
por: Jesus, Sheile Pinheiro de, et al.
Publicado: (2018)

Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice
por: Jemon, K., et al.
Publicado: (2016)

Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
por: Chen, Jing, et al.
Publicado: (2019)

Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer
por: de Araújo Catão Zampronha, Rossana, et al.
Publicado: (2013)

Human Papillomavirus 16 and 18 Infection in Oral Cancer in Thailand: A Multicenter Study
por: Komolmalai, Nicha, et al.
Publicado: (2020)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada
por: Kohli, Michele, et al.
Publicado: (2012)

Erratum to: Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
por: Chen, Jing, et al.
Publicado: (2020)

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
por: Hildesheim, Allan, et al.
Publicado: (2016)

Designing of CD8(+) and CD8(+)-overlapped CD4(+) epitope vaccine by targeting late and early proteins of human papillomavirus
por: Kaliamurthi, Satyavani, et al.
Publicado: (2018)

Safety of human papillomavirus 6, 11, 16 and 18 (recombinant): systematic review and meta-analysis
por: Coelho, Pedro Luiz Spinelli, et al.
Publicado: (2015)

Frequency of Human Papillomavirus (HPV) 16 and 18 Detection in Paraffin- Embedded Laryngeal Carcinoma Tissue
por: Hosseini, Seyed Zinab, et al.
Publicado: (2017)

Stability of trivalent human papillomavirus (types 16, 18, 58) recombinant vaccine (Escherichia coli)
por: Liu, Yu-Ying, et al.
Publicado: (2021)

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
por: Kohli, M, et al.
Publicado: (2007)

Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico
por: Rudolph, Samantha E., et al.
Publicado: (2016)

Prevalence of Human Papillomavirus Types 16/18 and Effect of Vaccination among Japanese Female General Citizens in the Vaccine Crisis Era
por: Kitamura, Tadaichi, et al.
Publicado: (2023)

Single-Cell Analyses Identify Dysfunctional CD16(+) CD8 T Cells in Smokers
por: Martos, Suzanne N., et al.
Publicado: (2020)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases
por: Mori, Seiichiro, et al.
Publicado: (2014)

Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania()()
por: Brown, Joelle, et al.
Publicado: (2014)

Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions
por: Torres-Rojas, Francisco Israel, et al.
Publicado: (2018)

Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia
por: Baba, Satoshi, et al.
Publicado: (2020)

Searching for the methylation sites involved in human papillomavirus type 16 and 18‑positive women with cervical cancer
por: Ma, Yanyun, et al.
Publicado: (2022)

Expression of human papillomavirus 16 and 18 DNA in oral lichen planus using polymerase chain reaction
por: Vijayan, Aswathy K., et al.
Publicado: (2022)

Human papillomavirus type 16 and 18 viral loads as predictors associated with abnormal cervical cytology among women in Saudi Arabia
por: Obeid, D.A., et al.
Publicado: (2020)

Photochemical Synthesis and Properties of 1,6- and 1,8-Naphthalenophanes
por: Wessig, Pablo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ifvouq8ddo21upfjo901avsm3o